Thais Milioni Luciano

Thais Milioni Luciano

Auto-generated profile, based on publicly available information

Thais Milioni Luciano

Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, (SP), Brasil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
TLThais Milioni Luciano
Thais Milioni Luciano
MHMariana Peduti Halah
Mariana Peduti Halah
MSMariana Teresa Alves Sarti
Mariana Teresa Alves Sarti
VFVitor Gonçalves Floriano
Vitor Gonçalves Floriano
BFBENEDITO A L da FONSECA
BENEDITO A L da FONSECA
SASonir Antonini
Sonir Antonini
We assess the severity and frequency of diabetic ketoacidosis (DKA) in new-onset type 1 diabetes mellitus (T1D) patients and in patients with previous diagnosis of T1D in a referral Brazilian university hospital in the first five months of the COVID-19 pandemic. We also compare the data with data from pre-pandemic periods. Forty-three new-onset T1D patients were diagnosed between April and August of the years 2017, 2018, 2019, and 2020. During the COVID-19 pandemic, the number of new-onset T1D was [...] ABSTRACT We assess the severity and frequency of diabetic ketoacidosis (DKA) in new-onset type 1 diabetes mellitus (T1D) patients and in patients with previous diagnosis of T1D in a referral Brazilian university hospital in the first five months of the COVID-19 pandemic. We also compare the data with data from pre-pandemic periods. Forty-three new-onset T1D patients were diagnosed between April and August of the years 2017, 2018, 2019, and 2020. During the COVID-19 pandemic, the number of new-onset T1D was

8 April 2026 in Journal of Pediatric Endocrinology and Diabetes
Verified
Journal Article
Open access
PDF file
TLThais Milioni Luciano
Thais Milioni Luciano
COCamila Freitas Oliveira
Camila Freitas Oliveira
We report a rare case of thyroid abscess associated with transient hyperthyroidism in a previously healthy adolescent. A 14-year-old girl presented with anterior neck pain progressing to swelling, fever, erythema, asthenia, and weight loss over 12 days. Imaging revealed a large abscess in the left thyroid lobe with tracheal deviation. Laboratory tests showed thyrotoxicosis. The patient underwent two drainage procedures, received antibiotic therapy, and a short course of antithyroid medication, evolving with complete clinical and biochemical recovery. Thyroid abscess should be considered in cases of painful cervical swelling associated with hyperthyroidism, as thyroid function may normalize after appropriate treatment.

19 September 2025 in Jornal de Pediatria
Verified
Journal Article
Open access
TLThais Milioni Luciano
Thais Milioni Luciano
MSMônica Freire Stecchini
Mônica Freire Stecchini
SASonir Antonini
Sonir Antonini
To evaluate the patterns of pubertal development, growth, and adult height in untreated male patients with CDGP. A retrospective study was conducted at a tertiary care center from 1984 to 2019. Medical records of 46 boys diagnosed with CDGP (after excluding those with hypogonadism) were included for further analysis. Most patients were born at term (78%) and appropriate for gestational age (85%). A family history of delayed puberty was noted in 50%. The median age at initial evaluation was 14.3 years (range: 4.8-16.2 years). Short stature before puberty was the main reason for seeking medical attention (48%). Short stature was common at the first evaluation (93%) but improved over time; at the final assessment, only 17% of the patients remained short. For those who reached adult height, the height Z-scores were comparable to target height. Predictions using the Bayley-Pinneau method often overestimated adult height. Delayed bone age was present in 82% of patients at initial evaluation. The median age of spontaneous pubertal onset was 15 years, with a median duration of 2.1 years (range: 1.2-4.8 years, n = 33). None of the patients received pharmacological treatment. The median age at Tanner stage G5 was 17.1 years. In boys with CDGP, transient short stature improved spontaneously during puberty. Most achieved their target height without growth-promoting therapy. However, adult height predictions based on the Bayley-Pinneau method were often overestimated. Spontaneous puberty initiation and completion occurred at approximately 15 and 17 years of age, respectively.

30 June 2026 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
TLThais Milioni Luciano
Thais Milioni Luciano
MHMariana Peduti Halah
Mariana Peduti Halah
LPLuís Eduardo Cruvinel Pinto
Luís Eduardo Cruvinel Pinto
MCMayara Souza Ribas Castor
Mayara Souza Ribas Castor
VNVania dos Santos Nunes Nogueira
Vania dos Santos Nunes Nogueira
SASonir Antonini
Sonir Antonini
Context: Idiopathic premature adrenarche (IPA) has been associated with a higher risk of metabolic and reproductive dysfunction, but long-term/adult outcomes remain incompletely known. Objective: To assess the relationship between IPA and metabolic syndrome, as well as polycystic ovarian syndrome, in premenarcheal adolescent and adult women. Methods: We conducted a systematic review and meta-analysis of observational studies reporting outcomes in females with IPA after menarche. Databases were searched through February 2025. Primary outcomes included BMI, insulin resistance markers, and clinical and biochemical markers of hyperandrogenism. Data were pooled using random-effects models. The GRADE approach was applied to assess the certainty of evidence. Results: A total of 21 studies comprising 635 females with IPA and 307 age-matched controls were included. Compared to controls, IPA individuals showed significantly higher BMI (MD: 1.4; CI: 1.0 to 1.9), fasting insulin, and HOMA-IR, indicating persistent insulin resistance. Markers of hyperandrogenism, including Ferriman-Gallwey score, DHEAS, and FAI, were also elevated. Secondary analyses revealed higher triglycerides, lower HDL, increased leptin, and greater carotid intima-media thickness, supporting an early pattern of cardiometabolic risk. GRADE assessment rated most outcomes as low certainty. Conclusion: Women with a history of IPA are at increased risk of long-term insulin resistance and hyperandrogenism, with early signs of adverse cardiometabolic profiles. These findings support the need for long-term monitoring in this population.

1 January 2026 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
KOKettyuscia Coelho e Oliveira
Kettyuscia Coelho e Oliveira
MHMariana Peduti Halah
Mariana Peduti Halah
LPLuís Eduardo Cruvinel Pinto
Luís Eduardo Cruvinel Pinto
TLThaís Milioni Luciano
Thaís Milioni Luciano
RSRyann Luccas de M. Souza
Ryann Luccas de M. Souza
SASonir Antonini
Sonir Antonini
Objective: This study evaluated the QoL of Brazilian adult patients with childhood-onset growth hormone deficiency GHD (CO-GHD), comparing those who continued GH replacement therapy (GHRT) after transition to adulthood with those who discontinued treatment and with healthy subjects. Subjects and methods: In this cross-sectional study, quality of life (QoL) was assessed using the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in 61 Brazilian adults aged 18-50 years. The sample included 31 patients with CO-GHD confirmed during the transition period, who continued or discontinued GHRT, and 30 matched controls. Results: GHD patients had poorer QoL, as indicated by higher QoLAGHDA scores than controls (median 8 [IQR 5-14] vs 4 [IQR 2-8]; p < 0.01). Continued GHRT in adulthood did not impact QoL compared with discontinued GHRT (8 [IQR 6-16] vs. 9 [IQR 5-12], p = 0.33). Overall, women had lower QoL irrespective of GHD (9 [IQR 6-13] vs. 5 [IQR 2-8.5], p = 0.01, women and men, respectively). We found no association between QoL-AGHDA scores and education level (p = 0.51), short stature (p = 0.78), associated pituitary deficiencies (p = 0.34), or overweight/obesity (p = 0.16). Conclusion: GHD impairs quality of life in young adults; however, our cross-sectional cohort did not show significant improvements in quality of life associated with GH replacement therapy. A multidisciplinary approach combining individualized treatment and psychosocial interventions remains essential.

31 December 2025 in Medicina (Ribeirão Preto)
Verified
Journal Article
Open access
PDF file
KBKarin Barszcz
Karin Barszcz
TMThais Milioni
Thais Milioni
RARicardo Fernando Arrais
Ricardo Fernando Arrais
RJRaphael Del Roio Liberatore Junior
Raphael Del Roio Liberatore Junior
Introdução: O Diabetes mellitus (DM) é uma condição clínica comum com múltiplas apresentações, sendo o diagnóstico diferencial entre diabetes tipo 1, tipo 2 e Maturity Onset Diabetes of the Young (MODY) um desafio frequente. MODY é uma forma rara de diabetes monogênico, caracterizada por um padrão hereditário distinto e critérios diagnósticos específicos. Objetivo: Este estudo visa descrever o perfil clínico e laboratorial de pacientes com suspeita de MODY atendidos no Ambulatório de Diabetes Infantil (AENDI) do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto – USP (HC-FMRP-USP). Métodos: Estudo transversal retrospectivo realizado entre 2012 e 2022, com análise de 12 prontuários de pacientes com suspeita de MODY acompanhados no AENDI. Foram coletados dados demográficos, antropométricos, sintomas, tratamento, exames laboratoriais e histórico familiar, além da aplicação da calculadora de predição para MODY. As análises foram realizadas utilizando estatísticas descritivas. Resultados: Dos pacientes acompanhados no AENDI, apenas 1,25% foram classificados com suspeita de MODY. Nenhum paciente da amostra foi diagnosticado com obesidade. Polidipsia, polifagia, poliúria e perda de peso foram observados em 22,22%, 25%, 44,44% e 28,57% dos casos, respectivamente. A terapia medicamentosa não foi necessária em 66,67% dos pacientes; quando indicada, 50% necessitam de antidiabético oral. A média de glicemia de jejum e hemoglobina glicada foi de 128 mg/dL e 6,02%, respectivamente. Histórico familiar de diabetes em familiares de primeiro e segundo grau foi positivo em 91,66% dos casos. A análise molecular dos genes associados ao MODY foi realizada, mas os resultados ainda não estão disponíveis. Conclusão: Os achados sugerem que a calculadora de predição para MODY é uma ferramenta útil na triagem de pacientes com alta probabilidade de MODY. A criação de protocolos específicos para o rastreamento e acompanhamento desses pacientes é essencial para assegurar um diagnóstico preciso e um manejo clínico adequado.